J L Shenep. Show Affiliations »
Abstract
Mesh: See more » AnimalsAnti-Bacterial Agents/administration & dosageAnti-Bacterial Agents/adverse effectsAnti-Bacterial Agents/therapeutic useBacterial Infections/drug therapyBacterial Infections/microbiologyBacterial Infections/therapyBacteriolysisCiprofloxacinEndotoxins/metabolismEscherichia coli/drug effectsEscherichia coli/metabolismGram-Negative Bacteria/drug effectsGram-Negative Bacteria/metabolismHumansNeisseria meningitidis/metabolismPolymyxin B/metabolismPolymyxin B/pharmacologyQuinolines/pharmacologyShock, Septic/drug therapyShock, Septic/microbiologyShock, Septic/therapy
Substances: See more » Anti-Bacterial AgentsEndotoxinsQuinolinesCiprofloxacinPolymyxin B
Year: 1986 PMID: 2938943 DOI: 10.1007/bf02013453
Source DB: PubMed Journal: Eur J Clin Microbiol ISSN: 0722-2211 Impact factor: 3.267